TY - JOUR
T1 - Suppression of cell migration by protein kinase Cδ
AU - Jackson, Desmond
AU - Zheng, Yang
AU - Lyo, Donggon
AU - Shen, Yinjie
AU - Nakayama, Keiko
AU - Nakayama, Keiichi I.
AU - Humphries, Michael J.
AU - Reyland, Mary E.
AU - Foster, David A.
N1 - Funding Information:
We thank Shigeo Ohno (Yokohama) for generously providing the PKCd expression vector used in this study. This study was supported by National Institutes of Health grants RO1-CA46677 and SO6-GM60654. DJ was supported by a minority supplement to CA46677. Research Centers in Minority Institutions award RR-03037 from the National Center for Research Resources of the National Institutes of Health, which supports infrastructure and instrumentation in the Biological Sciences Department at Hunter College, is also acknowledged.
PY - 2005/4/21
Y1 - 2005/4/21
N2 - The ability of cancer cells to migrate is strongly correlated with malignant progression and metastasis. Survival signals that suppress apoptosis have also been linked to increased cell motility. We previously reported that suppression of protein kinase Cδ (PKCδ) provided survival signals in a rat fibroblast model system. These studies have been extended to human breast cancer cells with differential cell motilities and PKCδ levels. BT-549 cells, which lack detectable expression of PKCδ, migrate very efficiently, whereas MCF-7 cells, which express high levels of PKCδ, migrate very poorly. Ectopic expression of PKCδ suppressed cell migration in the BT-549 cells, and downregulation of PKCδ enhanced cell migration in the MCF-7 cells. Downregulation of PKCδ in the MCF-7 cells also led to increased secretion of the matrix metalloprotease MMP-9. The migration of mouse embryo fibroblasts (MEFs) from wild type and PKCδ knockout mice was also examined and MEFs from PKCδ knockout mice had a five-fold increase in eel migration relative to the wild-type MEFs. These data provide evidence that PKCδ suppresses cell migration in both human breast cancer cells and in primary mouse fibroblasts, and indicate that the loss of PKCδ in human cancers could contribute to both eel survival and metastasis.
AB - The ability of cancer cells to migrate is strongly correlated with malignant progression and metastasis. Survival signals that suppress apoptosis have also been linked to increased cell motility. We previously reported that suppression of protein kinase Cδ (PKCδ) provided survival signals in a rat fibroblast model system. These studies have been extended to human breast cancer cells with differential cell motilities and PKCδ levels. BT-549 cells, which lack detectable expression of PKCδ, migrate very efficiently, whereas MCF-7 cells, which express high levels of PKCδ, migrate very poorly. Ectopic expression of PKCδ suppressed cell migration in the BT-549 cells, and downregulation of PKCδ enhanced cell migration in the MCF-7 cells. Downregulation of PKCδ in the MCF-7 cells also led to increased secretion of the matrix metalloprotease MMP-9. The migration of mouse embryo fibroblasts (MEFs) from wild type and PKCδ knockout mice was also examined and MEFs from PKCδ knockout mice had a five-fold increase in eel migration relative to the wild-type MEFs. These data provide evidence that PKCδ suppresses cell migration in both human breast cancer cells and in primary mouse fibroblasts, and indicate that the loss of PKCδ in human cancers could contribute to both eel survival and metastasis.
UR - http://www.scopus.com/inward/record.url?scp=18344390740&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=18344390740&partnerID=8YFLogxK
U2 - 10.1038/sj.onc.1208465
DO - 10.1038/sj.onc.1208465
M3 - Article
C2 - 15735725
AN - SCOPUS:18344390740
SN - 0950-9232
VL - 24
SP - 3067
EP - 3072
JO - Oncogene
JF - Oncogene
IS - 18
ER -